118. Myelomeningocele Clinical trials / Disease details
Clinical trials : 10 / Drugs : 18 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 12
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04027374 (ClinicalTrials.gov) | July 1, 2019 | 16/7/2019 | Stress-associated Epigenetic Alterations in Newborns After Fetal Surgery | Epigenetic Alterations in Stress Regulation Genes Among Newborns After Fetal Surgery for Myelomeningocele Repair: An Exploratory Study | Meningomyelocele | Procedure: Fetal surgery for MMC repair | University Children's Hospital, Zurich | University of Zurich;Psychiatric University Hospital, Zurich | Recruiting | N/A | 3 Months | All | 90 | Switzerland | |
| 2 | JPRN-UMIN000040088 | 2019/07/01 | 07/04/2020 | Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele | Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele - Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele | Myelomeningocele | MMC(Myelomeningocele) open fetal surgery | OSAKA UniversityDepartment of MedicineDivision of Obstetrics and Gynecology | NULL | Recruiting | 20years-old | Not applicable | Female | 15 | Not selected | Japan |
| 3 | NCT03936322 (ClinicalTrials.gov) | May 7, 2019 | 1/5/2019 | Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study | Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study | Spina Bifida;Myelomeningocele;Neural Tube Defects | Device: Minimally invasive fetoscopic repair of MMC | Mayo Clinic | NULL | Active, not recruiting | 18 Years | N/A | Female | 3 | N/A | United States |